Scohia Pharma is a legitimate, well-funded Japanese biotechnology company (spun out of Takeda) with significant capitalization (~$91M) and a robust pipeline targeting high-demand metabolic diseases like obesity and diabetes. However, the submission itself is of very low quality, containing demonstrably false claims about user adoption ('most people have used my product') and reach ('everyone'). While the underlying business is highly valuable and technically innovative, the Proof of Usefulness score is penalized by the inaccurate data provided in the submission.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline